These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7247902)

  • 21. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
    Misu Y; Goshima Y; Ueda H; Kubo T
    J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced suppression of a conditioned avoidance response by haloperidol but not phenoxybenzamine in rats with bilateral parafascicular lesions.
    Ahlenius S
    Exp Brain Res; 1980; 40(2):164-9. PubMed ID: 7428873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of disulfiram, phenoxybenzamine and propranolol on the behaviors evoked by apomorphine and amphetamine in adult cats.
    Motles E; Tetas M; Gomez A; Briones C; Gonzalez M
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):985-1001. PubMed ID: 1513935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
    Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pimozide on the increase of muscarinic receptors caused by mazindol and apomorphine in the rat cerebral motor cortex.
    de-Sousa FC; Marinho MM; Aguiar GV; Viana GS
    Braz J Med Biol Res; 1995 Jan; 28(1):113-9. PubMed ID: 7581019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible peripheral adrenergic and central dopaminergic influences in memory consolidation.
    Gozzani JL; Izquierdo I
    Psychopharmacology (Berl); 1976 Aug; 49(1):109-11. PubMed ID: 822441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apomorphine anorexia: a further pharmacological characterization.
    Muscat R; Willner P; Towell A
    Eur J Pharmacol; 1986 Apr; 123(1):123-31. PubMed ID: 2872073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature of receptors involved in apomorphine responses in pigeons.
    Saxena PN; Chawla N; Johri MB; Iqbal S
    Psychopharmacology (Berl); 1977 Jun; 53(1):89-95. PubMed ID: 407618
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
    Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
    Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of pyrazidol on resistance of animals to hypobaric hypoxia].
    Goroshinskaia IA; Nemashkalova LA; Khodakova AA; Sherstnev KB
    Biull Eksp Biol Med; 1992 Sep; 114(9):268-9. PubMed ID: 1477352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of alpha-adrenergic blocking agents on stereotyped behavior induced by apomorphine in rats.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1982 Jul; 15(2-3):143-6. PubMed ID: 6891277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three main factors in rat shuttle behavior: their pharmacology and sequential entry in operation during a two-way avoidance session.
    Izquierdo I; Cavalheiro EA
    Psychopharmacology (Berl); 1976 Sep; 49(2):145-57. PubMed ID: 825901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apomorphine-induced myocardial protection is due to antioxidant and not adrenergic/dopaminergic effects.
    Khaliulin I; Schneider A; Houminer E; Borman JB; Schwalb H
    Free Radic Biol Med; 2006 May; 40(10):1713-20. PubMed ID: 16678010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests.
    Reis FL; Masson S; de Oliveira AR; Brandão ML
    Pharmacol Biochem Behav; 2004 Oct; 79(2):359-65. PubMed ID: 15501313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine and central serotonin neurons.
    Grabowska M; Antkiewicz L; Maj J; Michaluk J
    Pol J Pharmacol Pharm; 1973; 25(1):29-39. PubMed ID: 4272897
    [No Abstract]   [Full Text] [Related]  

  • 40. [Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
    Boissier JR; Simon P; Giudicelli JF
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):68-80. PubMed ID: 5689547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.